Načítá se...
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control
BACKGROUND: The management of asthma has changed since the introduction of budesonide/formoterol (Symbicort(®)) as both maintenance and reliever therapy (SMART). SMART and its effects on bronchial hyperresponsiveness (BHR) have not been studied in primary care. AIMS: To compare the effects of SMART...
Uloženo v:
| Vydáno v: | Prim Care Respir J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548307/ https://ncbi.nlm.nih.gov/pubmed/22015542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4104/pcrj.2011.00090 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|